Source: |
Type: |
SIRT1 (Sirtuin 1) is a protein that plays a crucial role in various cellular processes, including metabolism, stress resistance, and longevity. In the context of cancer, SIRT1 has been found to have both tumor-suppressing and tumor-promoting functions, depending on the type of cancer and the cellular context. Expression Promotes: Breast, Prostate, Colorectal Cancer. Expression Suppresses: Leukemia, Liver Cancers. -aging process is associated with the inactivation of the silent information regulator T1 (SIRT1) protein. |
2646- | AL, | Anti-Cancer Potential of Homemade Fresh Garlic Extract Is Related to Increased Endoplasmic Reticulum Stress |
- | in-vitro, | Pca, | DU145 | - | in-vitro, | Melanoma, | RPMI-8226 |
3433- | ALA, | Alpha lipoic acid promotes development of hematopoietic progenitors derived from human embryonic stem cells by antagonizing ROS signals |
3550- | ALA, | Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer's Disease? |
- | Review, | AD, | NA |
3435- | aLinA, | Alpha-linolenic acid-mediated epigenetic reprogramming of cervical cancer cell lines |
- | in-vitro, | Cerv, | HeLa | - | in-vitro, | Cerv, | SiHa | - | in-vitro, | Cerv, | C33A |
1093- | And, | Andrographolide attenuates epithelial‐mesenchymal transition induced by TGF‐β1 in alveolar epithelial cells |
- | in-vitro, | Lung, | A549 |
3396- | ART/DHA, | Progress on the study of the anticancer effects of artesunate |
- | Review, | Var, | NA |
2292- | Ba, | BA, | Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: A comprehensive review with future perspectives |
- | Review, | Var, | NA |
4263- | CA, | Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action |
- | Review, | AD, | NA |
1263- | CAP, | Capsaicin inhibits the migration and invasion via the AMPK/NF-κB signaling pathway in esophagus sequamous cell carcinoma by decreasing matrix metalloproteinase-9 expression |
- | in-vitro, | ESCC, | Eca109 |
1517- | CAP, | Capsaicin Inhibits Multiple Bladder Cancer Cell Phenotypes by Inhibiting Tumor-Associated NADH Oxidase (tNOX) and Sirtuin1 (SIRT1) |
- | in-vitro, | Bladder, | TSGH8301 | - | in-vitro, | CRC, | T24 |
2652- | CAP, | Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence |
- | Review, | Var, | NA |
3635- | Croc, | A Review of Potential Efficacy of Saffron (Crocus sativus L.) in Cognitive Dysfunction and Seizures |
- | Review, | NA, | NA |
3795- | CUR, | Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence |
- | Review, | AD, | NA |
3862- | CUR, | RES, | The metalloproteinase ADAM10: A useful therapeutic target? |
- | Review, | AD, | NA |
1844- | dietFMD, | Unlocking the Potential: Caloric Restriction, Caloric Restriction Mimetics, and Their Impact on Cancer Prevention and Treatment |
- | Review, | NA, | NA |
1863- | dietFMD, | Chemo, | Effect of fasting on cancer: A narrative review of scientific evidence |
- | Review, | Var, | NA |
1621- | EA, | The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art |
- | Review, | Var, | NA |
1605- | EA, | Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence |
- | Review, | Var, | NA |
3246- | EGCG, | Epigallocatechin gallate suppresses hepatic cholesterol synthesis by targeting SREBP-2 through SIRT1/FOXO1 signaling pathway |
- | in-vitro, | Nor, | NA |
3222- | EGCG, | Epigallocatechin gallate and mitochondria—A story of life and death |
- | Review, | Nor, | NA |
3716- | FA, | Ferulic Acid as a Protective Antioxidant of Human Intestinal Epithelial Cells |
- | in-vitro, | IBD, | NA | - | in-vivo, | NA, | NA |
1961- | GamB, | Effects of gambogic acid on the activation of caspase-3 and downregulation of SIRT1 in RPMI-8226 multiple myeloma cells via the accumulation of ROS |
- | in-vitro, | Melanoma, | RPMI-8226 |
2503- | H2, | Brain Metastases Completely Disappear in Non-Small Cell Lung Cancer Using Hydrogen Gas Inhalation: A Case Report |
- | Case Report, | Lung, | NA |
3776- | H2, | The role of hydrogen in Alzheimer's disease |
- | Review, | AD, | NA |
3774- | H2, | The role of hydrogen in Alzheimer’s disease |
- | Review, | AD, | NA |
3773- | H2, | Role and mechanism of molecular hydrogen in the treatment of Parkinson’s diseases |
- | Review, | Park, | NA |
3770- | H2, | Role of Molecular Hydrogen in Ageing and Ageing-Related Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3766- | H2, | The role of hydrogen in Alzheimer′s disease |
- | Review, | AD, | NA |
2891- | HNK, | Honokiol, an Active Compound of Magnolia Plant, Inhibits Growth, and Progression of Cancers of Different Organs |
- | Review, | Var, | NA |
2919- | LT, | Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence |
- | Review, | Var, | NA |
2921- | LT, | Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies |
- | Review, | Nor, | NA |
2589- | LT, | Chemo, | Luteolin Inhibits Breast Cancer Stemness and Enhances Chemosensitivity through the Nrf2-Mediated Pathway |
- | in-vitro, | BC, | MDA-MB-231 |
4338- | LT, | Luteolin: a natural product with multiple mechanisms for atherosclerosis |
- | Review, | NA, | NA |
3277- | Lyco, | Recent trends and advances in the epidemiology, synergism, and delivery system of lycopene as an anti-cancer agent |
- | Review, | Var, | NA |
2938- | NAD, | NAD+ supplementation limits triple-negative breast cancer metastasis via SIRT1-P66Shc signaling |
- | in-vivo, | BC, | NA |
2937- | NAD, | High-Dosage NMN Promotes Ferroptosis to Suppress Lung Adenocarcinoma Growth through the NAM-Mediated SIRT1-AMPK-ACC Pathway |
- | in-vitro, | Lung, | A549 |
2936- | NAD, | The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update |
2932- | NAD, | Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment |
- | in-vitro, | Nor, | NA |
2933- | NAD, | Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns |
- | Review, | Nor, | NA | - | NA, | AD, | NA | - | NA, | Diabetic, | NA | - | NA, | Stroke, | NA | - | NA, | LiverDam, | NA | - | NA, | Park, | NA |
2077- | PB, | Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells |
- | in-vitro, | Liver, | HUH7 |
3587- | PI, | Piperine: A review of its biological effects |
- | Review, | Park, | NA | - | Review, | AD, | NA |
2963- | PL, | Piperlongumine activates Sirtuin1 and improves cognitive function in a murine model of Alzheimer’s disease |
- | in-vitro, | AD, | HEK293 |
3919- | PTS, | Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease |
- | in-vivo, | AD, | NA |
2339- | QC, | Quercetin protects against LPS-induced lung injury in mice via SIRT1-mediated suppression of PKM2 nuclear accumulation |
- | in-vivo, | Nor, | NA |
2338- | QC, | Quercetin: A Flavonoid with Potential for Treating Acute Lung Injury |
- | Review, | Nor, | NA |
3350- | QC, | Quercetin and the mitochondria: A mechanistic view |
- | Review, | NA, | NA |
3365- | QC, | Quercetin attenuates sepsis-induced acute lung injury via suppressing oxidative stress-mediated ER stress through activation of SIRT1/AMPK pathways |
- | in-vivo, | Sepsis, | NA |
3534- | QC, | Lyco, | Synergistic protection of quercetin and lycopene against oxidative stress via SIRT1-Nox4-ROS axis in HUVEC cells |
- | in-vitro, | Nor, | HUVECs |
3607- | QC, | Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More |
- | Review, | AD, | NA | - | Review, | Park, | NA |
1506- | RES, | Epigenetic targets of bioactive dietary components for cancer prevention and therapy |
- | Review, | NA, | NA |
1282- | RES, | Resveratrol Inhibits CD4+ T Cell Activation by Enhancing the Expression and Activity of Sirt1 |
- | vitro+vivo, | NA, | NA |
2331- | RES, | Resveratrol improves follicular development of PCOS rats via regulating glycolysis pathway and targeting SIRT1 |
- | in-vivo, | Nor, | NA |
2332- | RES, | Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism |
- | Review, | Var, | NA |
2472- | RES, | Resveratrol Restores Sirtuin 1 (SIRT1) Activity and Pyruvate Dehydrogenase Kinase 1 (PDK1) Expression after Hemorrhagic Injury in a Rat Model |
- | in-vivo, | Nor, | NA |
2566- | RES, | A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke |
- | Review, | Stroke, | NA |
3069- | RES, | Resveratrol Inhibits NLRP3 Inflammasome-Induced Pyroptosis and miR-155 Expression in Microglia Through Sirt1/AMPK Pathway |
- | in-vitro, | Nor, | N9 |
3080- | RES, | Resveratrol: A miraculous natural compound for diseases treatment |
- | Review, | Var, | NA |
3068- | RES, | Resveratrol decreases the expression of genes involved in inflammation through transcriptional regulation |
- | in-vitro, | lymphoma, | U937 |
3071- | RES, | Resveratrol and Its Anticancer Effects |
- | Review, | Var, | NA |
3074- | RES, | Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer |
- | Review, | BC, | NA |
3075- | RES, | Rad, | The Protection Effect of Resveratrol Against Radiation-Induced Inflammatory Bowel Disease via NLRP-3 Inflammasome Repression in Mice |
- | in-vivo, | Nor, | NA |
3076- | RES, | Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells |
- | Review, | Var, | NA |
3079- | RES, | Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action |
- | Review, | Var, | NA |
3061- | RES, | The Anticancer Effects of Resveratrol: Modulation of Transcription Factors |
- | Review, | Var, | NA |
3059- | RES, | Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury |
- | in-vivo, | Nor, | HK-2 |
3057- | RES, | The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
3100- | RES, | Neuroprotective effects of resveratrol in Alzheimer disease pathology |
- | Review, | AD, | NA |
3099- | RES, | Resveratrol and cognitive decline: a clinician perspective |
- | Review, | Nor, | NA | - | NA, | AD, | NA |
3096- | RES, | Identification of potential target genes of non-small cell lung cancer in response to resveratrol treatment by bioinformatics analysis |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H1299 |
3092- | RES, | Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action |
- | Review, | BC, | MDA-MB-231 | - | Review, | BC, | MCF-7 |
2687- | RES, | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | NA, | NA | - | Review, | AD, | NA |
3614- | RES, | Resveratrol--a boon for treating Alzheimer's disease? |
- | Review, | AD, | NA |
3613- | RES, | Resveratrol for Alzheimer's disease |
- | Review, | AD, | NA |
3612- | RES, | Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential |
- | Review, | AD, | NA |
3798- | RES, | Resveratrol reverses hippocampal synaptic markers injury and SIRT1 inhibition against developmental Pb exposure |
- | in-vivo, | NA, | NA |
4286- | RES, | Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease |
- | Review, | AD, | NA |
4284- | RES, | Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex |
- | in-vitro, | AD, | HEK293 | - | NA, | Stroke, | NA | - | in-vivo, | AD, | NA |
3006- | RosA, | Rosmarinic acid attenuates glioblastoma cells and spheroids’ growth and EMT/stem-like state by PTEN/PI3K/AKT downregulation and ERK-induced apoptosis |
- | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | LN229 |
4190- | Sesame, | Sesame Seeds: A Nutrient-Rich Superfood |
- | Review, | NA, | NA |
3648- | SIL, | Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years |
- | Review, | NA, | NA |
3282- | SIL, | Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions |
- | Review, | NA, | NA |
2217- | SK, | Shikonin Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis to Attenuate Renal Ischemia/Reperfusion Injury by Activating the Sirt1/Nrf2/HO-1 Pathway |
- | in-vivo, | Nor, | NA | - | in-vitro, | Nor, | HK-2 |
2220- | SK, | Shikonin Alleviates Gentamicin-Induced Renal Injury in Rats by Targeting Renal Endocytosis, SIRT1/Nrf2/HO-1, TLR-4/NF-κB/MAPK, and PI3K/Akt Cascades |
- | in-vivo, | Nor, | NA |
2188- | SK, | Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment |
- | Review, | Var, | NA |
1193- | SM, | Cryptotanshinone from the Salvia miltiorrhiza Bunge Attenuates Ethanol-Induced Liver Injury by Activation of AMPK/SIRT1 and Nrf2 Signaling Pathways |
- | in-vivo, | Alcohol, | NA | - | in-vitro, | Liver, | HepG2 |
400- | SNP, | MF, | Polyvinyl Alcohol Capped Silver Nanostructures for Fortified Apoptotic Potential Against Human Laryngeal Carcinoma Cells Hep-2 Using Extremely-Low Frequency Electromagnetic Field |
- | in-vitro, | Laryn, | HEp2 |
2206- | SNP, | RES, | ENHANCED EFFICACY OF RESVERATROL-LOADED SILVER NANOPARTICLE IN ATTENUATING SEPSIS-INDUCED ACUTE LIVER INJURY: MODULATION OF INFLAMMATION, OXIDATIVE STRESS, AND SIRT1 ACTIVATION |
- | in-vivo, | Nor, | NA |
3420- | TQ, | Thymoquinone alleviates the accumulation of ROS and pyroptosis and promotes perforator skin flap survival through SIRT1/NF-κB pathway |
- | in-vitro, | Nor, | HUVECs | - | in-vitro, | NA, | NA |
3423- | TQ, | Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics |
- | Review, | Var, | NA |
3422- | TQ, | Thymoquinone, as a Novel Therapeutic Candidate of Cancers |
- | Review, | Var, | NA |
4031- | VitB3, | Nicotinamide Riboside-The Current State of Research and Therapeutic Uses |
- | Review, | NA, | NA |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:634 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid